Literature DB >> 17296810

Capecitabine.

Jan H M Schellens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17296810     DOI： 10.1634/theoncologist.12-2-152

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  16 in total

1.  Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study.

Authors:  Xiaohui Zhang; Yidong Zhou; Feng Mao; Yan Lin; Jinghong Guan; Qiang Sun
Journal:  Med Oncol       Date:  2015-09-07       Impact factor: 3.064

2.  Capecitabine-induced hyperglycemia without hyperlipidemia: a case report.

Authors:  Amar Avishek; Mathaiyan Jayanthi; Dubashi Biswajit
Journal:  Eur J Clin Pharmacol       Date:  2017-07-27       Impact factor: 2.953

Review 3.  Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.

Authors:  Frederik E Stuurman; Bastiaan Nuijen; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

4.  Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.

Authors:  Anupama Suresh; Akannsha Ganju; Evan Morgan; Marilly Palettas; Julie A Stephens; Joseph Liu; Michael Berger; Craig Vargo; Anne Noonan; Raquel Reinbolt; Mathew Cherian; Jeffrey VanDeusen; Sagar Sardesai; Robert Wesolowski; Daniel G Stover; Maryam Lustberg; Bhuvaneswari Ramaswamy; Nicole Williams
Journal:  Invest New Drugs       Date:  2020-01-14       Impact factor: 3.850

Review 5.  Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Authors:  Amandeep Thakur; Chetna Faujdar; Ram Sharma; Sachin Sharma; Basant Malik; Kunal Nepali; Jing Ping Liou
Journal:  J Med Chem       Date:  2022-07-05       Impact factor: 8.039

Review 6.  Breath tests to phenotype drug disposition in oncology.

Authors:  Frans L Opdam; Anil S Modak; Hans Gelderblom; Henk-Jan Guchelaar
Journal:  Clin Pharmacokinet       Date:  2013-11       Impact factor: 6.447

7.  Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva.

Authors:  S Camporesi
Journal:  Ecancermedicalscience       Date:  2008-11-12

8.  Capecitabine-Induced Coronary Vasospasm.

Authors:  Danish Henry; Francine Rudzik; Allison Butts; Aju Mathew
Journal:  Case Rep Oncol       Date:  2016-10-17

9.  Capecitabine-Associated Loss of Fingerprints: A Case Report of a 62-Year-Old Man With Colorectal Cancer Suffering From Capecitabine-Induced Adermatoglyphia.

Authors:  Tasneem Dawood; Muhammad Nauman Zahir; Muhammad Afzal; Yasmin Abdul Rashid
Journal:  Cureus       Date:  2021-06-08

Review 10.  Role of capecitabine in treating metastatic colorectal cancer in Chinese patients.

Authors:  Feng Wang; Feng-Hua Wang; Long Bai; Rui-Hua Xu
Journal:  Onco Targets Ther       Date:  2014-04-02       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.